Fantes F E, Heuer D K, Parrish R K, Sossi N, Gressel M G
Arch Ophthalmol. 1985 Jul;103(7):953-5. doi: 10.1001/archopht.1985.01050070079034.
Postoperative subconjunctival fluorouracil injections may be a useful adjunct to standard glaucoma filtering surgery in eyes that are at high risk of failure. Topical administration would be preferable to subconjunctival administration; however, there are no data on the ocular penetration of topically applied fluorouracil. Consequently, we investigated the pharmacokinetics of topically administered fluorouracil labeled with carbon 14 in normal rabbit eyes. One drop (approximately 2.4 mg) of fluorouracil resulted in the following concentrations at 0.5 and six hours, respectively: 17.3 and 0.9 micrograms/g of conjunctiva; 24.3 and 1.3 micrograms/g of cornea; 14.6 and 0.2 micrograms/mL of aqueous; 0.8 and 0.5 microgram/g of lens; 1.1 and 0.3 microgram/g of vitreous; and 0.2 and less than 0.1 microgram/mL of serum. Three drops (approximately 7.2 mg) of fluorouracil resulted in the following concentrations at 0.5 and eight hours, respectively: 589.8 and 1.3 micrograms/g of conjunctiva; 502.9 and 1.8 micrograms/g of cornea; 199.6 and 0.8 micrograms/mL of aqueous; 6.2 and 0.5 micrograms/g of lens; 6.8 and 0.5 micrograms/g of vitreous; and 1.3 and 0.2 microgram/mL of serum. Since a fluorouracil concentration of 0.2 microgram/mL inhibits rabbit conjunctival fibroblast proliferation in cell culture by 50%, these data suggest that topically applied fluorouracil achieves sufficient levels in the ocular compartments and tissues to have potential therapeutic applications.
对于有高失败风险的眼睛,术后结膜下注射氟尿嘧啶可能是标准青光眼滤过手术的一种有用辅助手段。局部给药比结膜下给药更可取;然而,关于局部应用氟尿嘧啶的眼内渗透率尚无数据。因此,我们研究了正常兔眼中局部应用碳14标记的氟尿嘧啶的药代动力学。一滴(约2.4毫克)氟尿嘧啶在0.5小时和6小时时分别产生以下浓度:结膜17.3和0.9微克/克;角膜24.3和1.3微克/克;房水14.6和0.2微克/毫升;晶状体0.8和0.5微克/克;玻璃体1.1和0.3微克/克;血清0.2和小于0.1微克/毫升。三滴(约7.2毫克)氟尿嘧啶在0.5小时和8小时时分别产生以下浓度:结膜589.8和1.3微克/克;角膜502.9和1.8微克/克;房水199.6和0.8微克/毫升;晶状体6.2和0.5微克/克;玻璃体6.8和0.5微克/克;血清1.3和0.2微克/毫升。由于氟尿嘧啶浓度为0.2微克/毫升可在细胞培养中抑制兔结膜成纤维细胞增殖50%,这些数据表明局部应用氟尿嘧啶在眼内各腔室和组织中达到了足以具有潜在治疗应用的水平。